Efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: a meta-analysis
At Elite Primary Care Group, patient education is at the heart of our practice
Back Warren, P (3 Dec 2023) 'Vincent Marks obituary', The Guardian
Demand for those medications has far outpaced supply over the past year, forcing Novo Nordisk and Eli Lilly, the dominant players in the market, to invest heavily to scale up manufacturing
Among emerging epidemiological indicators, the triglyceride-glucose body mass index (TyG-BMI)a simple surrogate marker of insulin resistancehas shown a positive association with CVD risk in individuals with CKM syndrome
The exact number of days varies by brand and even by formulation, so this is one of those times where reading the little paper insert that comes in the box genuinely matters